Page last updated: 2024-11-03

probenecid and Embolus

probenecid has been researched along with Embolus in 2 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walker, DW1
Curtis, B1
Lacey, B1
Nitsos, I1
Carroll, KF1
Long, FL1
Smith, RB1

Other Studies

2 other studies available for probenecid and Embolus

ArticleYear
Kynurenic acid in brain and cerebrospinal fluid of fetal, newborn, and adult sheep and effects of placental embolization.
    Pediatric research, 1999, Volume: 45, Issue:6

    Topics: Animals; Animals, Newborn; Brain; Brain Injuries; Embolism; Female; Fetal Hypoxia; Fetus; Kynurenic

1999
Complications in a patient with subacute bacterial endocarditis with particular reference to massive penicillin therapy.
    The Medical journal of Australia, 1969, Jun-21, Volume: 1, Issue:25

    Topics: Blood Protein Electrophoresis; Calcinosis; Embolism; Endocarditis, Subacute Bacterial; Femoral Arter

1969